Close

Ziopharm Oncology (ZIOP), Intrexon (XON) Enter Amended ECCs; Will Include Increased Investment

June 30, 2016 8:03 AM EDT Send to a Friend
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, and ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced amendments to their Exclusive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login